WO2007092465A3 - Topical delivery compositions - Google Patents

Topical delivery compositions Download PDF

Info

Publication number
WO2007092465A3
WO2007092465A3 PCT/US2007/003187 US2007003187W WO2007092465A3 WO 2007092465 A3 WO2007092465 A3 WO 2007092465A3 US 2007003187 W US2007003187 W US 2007003187W WO 2007092465 A3 WO2007092465 A3 WO 2007092465A3
Authority
WO
WIPO (PCT)
Prior art keywords
topical delivery
delivery compositions
compositions
topical
skin
Prior art date
Application number
PCT/US2007/003187
Other languages
French (fr)
Other versions
WO2007092465A2 (en
Inventor
Glenn Hoke
Original Assignee
Dyao Pharmaceutical Corp
Glenn Hoke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dyao Pharmaceutical Corp, Glenn Hoke filed Critical Dyao Pharmaceutical Corp
Publication of WO2007092465A2 publication Critical patent/WO2007092465A2/en
Publication of WO2007092465A3 publication Critical patent/WO2007092465A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention is generally related to products and methods that delivery pharmaceutical agents to the skin.
PCT/US2007/003187 2006-02-07 2007-02-05 Topical delivery compositions WO2007092465A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77105206P 2006-02-07 2006-02-07
US60/771,052 2006-02-07

Publications (2)

Publication Number Publication Date
WO2007092465A2 WO2007092465A2 (en) 2007-08-16
WO2007092465A3 true WO2007092465A3 (en) 2008-02-07

Family

ID=38345757

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/003187 WO2007092465A2 (en) 2006-02-07 2007-02-05 Topical delivery compositions

Country Status (1)

Country Link
WO (1) WO2007092465A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038728A1 (en) * 1996-04-15 1997-10-23 Dyad Pharmaceutical Corporation Combination therapy for androgenic alopecia with antisense oligonucleotides and minoxidil
WO2005042741A2 (en) * 2003-10-21 2005-05-12 Dyad Pharmaceutical Corporation METHODS AND COMPOSITIONS FOR TREATING 5alpha-REDUCTASE TYPE 1 AND TYPE 2 DEPENDENT CONDITIONS
US20050203026A1 (en) * 2003-11-06 2005-09-15 Day Anthony G. Peptides and supported peptides for treating skin diseases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997038728A1 (en) * 1996-04-15 1997-10-23 Dyad Pharmaceutical Corporation Combination therapy for androgenic alopecia with antisense oligonucleotides and minoxidil
WO2005042741A2 (en) * 2003-10-21 2005-05-12 Dyad Pharmaceutical Corporation METHODS AND COMPOSITIONS FOR TREATING 5alpha-REDUCTASE TYPE 1 AND TYPE 2 DEPENDENT CONDITIONS
US20050203026A1 (en) * 2003-11-06 2005-09-15 Day Anthony G. Peptides and supported peptides for treating skin diseases

Also Published As

Publication number Publication date
WO2007092465A2 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
WO2008116135A3 (en) Topical formulations having enhanced bioavailability
WO2007141392A3 (en) Compositions comprising betulonic acid
AU2007299727A8 (en) Self preserved aqueous pharmaceutical compositions
EP2045251A4 (en) Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2010127099A3 (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
EP2813223B8 (en) Metal delivery agents and therapeutic uses of the same
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2008070268A3 (en) Pharmaceutical compositions
PL2081547T3 (en) Galenic form for the trans-mucosal delivery of active ingredients
WO2008076954A3 (en) Heterocycle compounds and methods of use thereof
WO2007125105A3 (en) Benzamide glucokinase activators
JO2721B1 (en) Artemisinin Derivative Dimers, Their preparation and their therapeutic application
WO2011141685A3 (en) Systemic nasal compositions comprising cocoyl proline or at least one of the constituents thereof
EP2045253A4 (en) alpha-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT
WO2009071689A3 (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
WO2010021607A3 (en) Pharmaceutical formulation
GB0821730D0 (en) Assessment of the effects of topical administration of chemodenervating pharmaceuticals
HK1142536A1 (en) Gel useful for the delivery of cosmetic active ingredients
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
WO2007067784A3 (en) Liposomal compositions
WO2010092088A3 (en) Use of hydrophobin as a spreading agent

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A DATED 19.11.2008.

122 Ep: pct application non-entry in european phase

Ref document number: 07763694

Country of ref document: EP

Kind code of ref document: A2